|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.200 CNY | -3.67% |
|
-4.11% | -24.05% |
| 25/05 | North China Pharma Gets China Nod for Kidney Anemia Drug | MT |
| 24/04 | North China Pharmaceutical Company.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 720.61Cr 105.93Cr 93Cr 86Cr 80Cr 150.3Cr 9.99TCr 153.42Cr 1.03TCr 398.18Cr 4.94TCr 397.78Cr 389.09Cr 17TCr | P/E 2024 |
69.9x | P/E 2025 | 51.7x |
|---|---|---|---|---|---|
| Enterprise Value | 1.69TCr 248.14Cr 217.57Cr 200.55Cr 187.76Cr 352.07Cr 23TCr 359.38Cr 2.41TCr 932.72Cr 12TCr 931.77Cr 911.43Cr 40TCr | EV / Sales 2024 |
1.89x | EV / Sales 2025 | 2.07x |
| Free-Float |
40.02% | Yield 2024 |
0.58% | Yield 2025 | 0.63% |
| 1 day | -3.67% | ||
| 1 week | -4.11% | ||
| Current month | -7.49% | ||
| 1 month | -6.25% | ||
| 3 months | -21.20% | ||
| 6 months | -25.27% | ||
| Current year | -24.05% |
| 1 week | 4.2 |  | 4.66 |
| 1 month | 4.2 | | 4.66 |
| Current year | 4.2 | | 6.07 |
| 1 year | 4.2 | | 7.46 |
| 3 years | 3.83 | | 7.46 |
| 5 years | 3.83 | | 13.45 |
| 10 years | 3.83 | | 20.24 |
| Manager | Title | Age | Since |
|---|---|---|---|
Min Zhang
CEO | Chief Executive Officer | 55 | 28/11/2025 |
Zhi Guang Xiao
DFI | Director of Finance/CFO | 46 | 10/04/2024 |
Jing Yang
IRC | Investor Relations Contact | 45 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Yao Cao
CHM | Chairman | 49 | 22/03/2016 |
Li Xin Wang
CHM | Chairman | 54 | 10/04/2023 |
Ji Gang Xie
BRD | Director/Board Member | 53 | 23/04/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/25/25 | Buy | Chairman | 1,600 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.67% | -4.11% | -31.71% | -24.19% | 105.93Cr | |
| +7.13% | +9.97% | +55.80% | +163.38% | 1,07700Cr | |
| +3.99% | +11.50% | +67.09% | +56.27% | 61TCr | |
| +4.20% | +17.03% | +38.97% | +91.19% | 45TCr | |
| +0.28% | +4.85% | +28.17% | +22.04% | 33TCr | |
| -0.56% | +7.26% | +40.85% | +26.86% | 29TCr | |
| -0.78% | +4.12% | +30.23% | +40.51% | 29TCr | |
| -1.63% | +4.37% | -28.79% | -41.31% | 21TCr | |
| +1.56% | +6.14% | +29.30% | +61.91% | 19TCr | |
| +3.26% | +3.33% | +15.55% | +67.87% | 16TCr | |
| Average | -0.70% | +7.31% | +24.55% | +46.45% | 36.17TCr | |
| Weighted average by Cap. | +0.25% | +9.65% | +41.63% | +80.71% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 986.96Cr 145.09Cr 127.21Cr 117.26Cr 109.78Cr 205.86Cr 14TCr 210.13Cr 1.41TCr 545.35Cr 6.76TCr 544.8Cr 532.91Cr 23TCr | 924.17Cr 135.86Cr 119.12Cr 109.8Cr 102.8Cr 192.76Cr 13TCr 196.76Cr 1.32TCr 510.66Cr 6.33TCr 510.14Cr 499Cr 22TCr |
| Net income | 13Cr 1.87Cr 1.64Cr 1.51Cr 1.41Cr 2.65Cr 176.1Cr 2.7Cr 18Cr 7.02Cr 87Cr 7.01Cr 6.86Cr 301.8Cr | 18Cr 2.69Cr 2.36Cr 2.17Cr 2.04Cr 3.82Cr 253.85Cr 3.9Cr 26Cr 10Cr 125.46Cr 10Cr 9.88Cr 435.03Cr |
| Net Debt | 978.97Cr 143.91Cr 126.18Cr 116.31Cr 108.89Cr 204.19Cr 14TCr 208.43Cr 1.4TCr 540.94Cr 6.71TCr 540.39Cr 528.59Cr 23TCr | 967.38Cr 142.21Cr 124.69Cr 114.94Cr 107.6Cr 201.77Cr 13TCr 205.96Cr 1.38TCr 534.54Cr 6.63TCr 534Cr 522.34Cr 23TCr |
Employees
9,972
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/26/26 | CN¥4.200 | -3.67% | 1,45,69,600 |
| 25/26/25 | CN¥4.360 | -2.90% | 1,81,80,868 |
| 24/26/24 | CN¥4.490 | +0.90% | 2,50,63,362 |
| 23/26/23 | CN¥4.450 | +2.53% | 2,10,83,865 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600812 Stock
Select your edition
All financial news and data tailored to specific country editions
